中年心肺适能与慢性阻塞性肺疾病长期风险
该研究纳入1970—1971年招募的4730名中年男性,用功率计测试确定VO2max并分低/正常/高心肺适能组,随访至多46年。结果显示正常和高心肺适能者发生COPD及死于COPD的风险均低于低心肺适能者,且反向因果检验未改变结果。
要点
- 中年心肺适能正常者发生COPD风险较低心肺适能者低21%,高者低31%。
- 中年心肺适能正常者死于COPD风险较低心肺适能者低35%,高者低62%。
- 正常和高心肺适能者发生COPD及死于COPD的时间较低心肺适能者延迟约1.3—1.8年。
核心结论
- 在健康中年男性人群中,较高的心肺适能水平与较低的长期新发COPD及COPD死亡风险相关。
研究设计与样本
- 研究为队列研究,1970—1971年招募中年男性n=4730,用心电图功率计测试确定VO2max,按年龄校正均值±1 Z-score分低、正常、高心肺适能组,随访至多46年,采用多因素校正Cox模型和限制性平均生存时间分析。
主要发现
- 与低心肺适能相比,正常心肺适能者新发COPD风险低21%(HR 0.79,95%CI 0.63—0.99),高心肺适能者低31%(HR 0.69,95%CI 0.52—0.91)。
- 与低心肺适能相比,正常心肺适能者死于COPD风险低35%(HR 0.65,95%CI 0.46—0.91),高心肺适能者低62%(HR 0.38,95%CI 0.23—0.61)。
- 限制性平均生存时间分析显示,正常和高心肺适能者较低心肺适能者新发COPD及死于COPD延迟约1.3—1.8年。
- 反向因果检验未改变上述结果。
关键数值与推荐
- 心肺适能分组以年龄校正均值的±1 Z-score(±1 SD)界定低、正常、高。
- 新发COPD风险:正常心肺适能HR 0.79(95%CI 0.63—0.99),高心肺适能HR 0.69(95%CI 0.52—0.91),均与低心肺适能比较。
- COPD死亡风险:正常心肺适能HR 0.65(95%CI 0.46—0.91),高心肺适能HR 0.38(95%CI 0.23—0.61),均与低心肺适能比较。
临床怎么用
- 对中年男性评估心肺适能可能有助于识别COPD长期高风险人群。
- 维持或提高中年心肺适能或可作为降低远期COPD发病与死亡风险的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Good midlife cardiorespiratory fitness (CRF) may reduce the risk of chronic obstructive pulmonary disease (COPD). Reverse causation may play a role if follow-up time is short. We examined the association between CRF and both incident COPD and COPD mortality in employed men with up to 46 years follow-up, which allowed us to account for reverse causality. METHODS: Middle-aged men (n=4730) were recruited in 1970-1971. CRF was determined as VO2max by ergometer test. Categories of CRF (low, normal, high) were defined as ± 1 Z-score (± 1 SD) above or below the age-adjusted mean. Endpoints were identified through national registers and defined as incident COPD, and death from COPD. Multi-adjusted Cox models and restricted mean survival times (RMST) were performed. RESULTS: Compared with low CRF, the estimated risk of incident COPD was 21% lower in participants with normal CRF (HR 0.79, 95% CI 0.63 to 0.99) and 31 % lower with high CRF (HR 0.69, 95% CI 0.52 to 0.91). Compared with low CRF, the risk of death from COPD was 35% lower in participants with normal CRF (HR 0.65, 95% CI 0.46 to 0.91) and 62% lower in participants with high CRF (HR 0.38, 95% CI 0.23 to 0.61). RMST showed a delay to incident COPD and death from COPD in the magnitude of 1.3-1.8 years in normal and high CRF vs low CRF. Test for reverse causation did not alter the results. CONCLUSION: In a population of healthy, middle-aged men, higher levels of CRF were associated with a lower long-term risk of incident COPD and death from COPD.
引用
- Hansen GM, Marott JL, Holtermann A, et al. Midlife cardiorespiratory fitness and the long-term risk of chronic obstructive pulmonary disease. Thorax. 2019. PMID: 31209150. doi:10.1136/thoraxjnl-2018-212821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。